Glioblastoma multiforme (GBM) has been considered the most aggressive glioma type. Temozolomide (TMZ) is the main first-line chemotherapeutic agent for GBM. Decreased mutS homolog 6 (MSH6) expression is clinically recognized as one of the principal reasons for GBM resistance to TMZ. However, the specific functions of MSH6 in GBM, in addition to its role in mismatch repair, remain unknown.
Hepatocellular carcinoma (HCC), the sixth most common malignancy worldwide, is characterized by a dismal prognosis due to high recurrence and metastasis rates. Thus, the need for the development of novel chemotherapeutic drugs is urgent. Cyclovirobuxine D (CVB-D), a steroidal alkaloid extracted from Buxus microphylla that has been extensively used to relieve the symptoms of cardiovascular diseases, has shown promising antineoplastic effects in recent studies. However, the therapeutic effects and underlying mechanisms of CVB-D on HCC remain largely unelucidated. This study experimentally indicated that CVB-D can repress HCC cell proliferation by arresting the cell cycle in G2 phase and can facilitate apoptosis. In addition, the migratory and invasive capabilities of HCC cells were noticeably attenuated by a nonlethal dose of CVB-D, and this attenuation was correlated with the inhibition of epithelial–mesenchymal transition (EMT). Moreover, in vivo , CVB-D displayed excellent anticancer effects in HCC tumor-bearing nude mice. Regarding the molecular mechanisms of CVB-D activity, decreased Slug expression was determined to be associated with the aforementioned anti-HCC functions of this extract, which might be regulated by epidermal growth factor receptor ( EGFR ) through the focal adhesion kinase ( FAK )-associated PI3K/AKT and MEK/ERK1/2 signaling pathways. Collectively, our results revealed the suppressive effects of CVB-D on progressive behaviors of HCC, including proliferation, migration, invasion, and EMT, in addition to its outstanding proapoptotic effects, which were correlated with the inhibition of the EGFR-FAK-AKT/ERK1/2-Slug signaling pathway. These discoveries provide an experimental and theoretical foundation for the use of CVB-D as a promising candidate for HCC therapy.
Thyroid function depends on the presence of certain elements necessary for both synthesis and metabolism of thyroid hormones. Deficiency or excess of certain elements may trigger biological abnormalities and cause thyroid diseases and even cancers. In this work, elemental analysis and identification of papillary thyroid cancer (PTC) tissues were investigated using laser-induced breakdown spectroscopy (LIBS). The PTC (n = 14) and normal (n = 13) thyroid tissue samples were obtained from PTC patients undergoing surgical resection of the thyroid gland. The biopsies were cut into 30 μm-thick slices from wax blocks, fixed on silicon slides, and ablated using a 1064 nm Q-switched Nd:YAG laser. Ten spectral emissions of calcium (Ca), magnesium (Mg), sodium (Na), potassium (K), carbon (C), oxygen (O), nitrogen (N), hydrogen (H), and molecular CN were compared between the PTC and normal tissues. This shows that Ca and Mg levels in the PTC tissues are significantly higher (p < 0.005) than those in the normal ones, suggesting that Ca and Mg may play important roles in the development and metabolic process of PTC. The ten emissions were further used to discriminate the PTC tissues from the normal ones, in combination with several chemometric methods, including principal component analysis (PCA), linear discriminant analysis (LDA) classifier, and support vector machine (SVM) classifier. Leave-one-out cross-validation shows that the PTC tissues can be discriminated from the normal ones. Total accuracies of 92.6% and 81.5% were obtained by the SVM classifier and LDA classifier, respectively. The corresponding sensitivity values were 0.929 and 0.714, respectively, and the specificity values were both 0.923. The results show that LIBS coupled with chemometric methods may serve as a potential tool for detection of papillary thyroid cancer.